Status:
COMPLETED
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
Lead Sponsor:
King Hussein Cancer Center
Conditions:
Genetic Predisposition
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aim to study the pattern and frequency of pathogenic variants among ALL newly diagnosed cancer patients in a genetically distinct population. Additionally, the investigators will st...
Eligibility Criteria
Inclusion
- Adult patient, age ≥ 18 years at time of cancer diagnosis
- Pathology proven diagnosis of cancer; any site, any stage (prior history of cancer is allowed)
- Jordanian nationality
- Willingness to participate
- Signed consent form
Exclusion
- Major psychiatric disorder (defined as: patients followed by a psychiatrist and on antipsychotic medications)
- Non-Jordanian
- Patients with Leukemia, Lymphoma and Myeloma
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04920513
Start Date
May 1 2021
End Date
February 1 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Hussein Cancer Center
Amman, Amman Governorate, Jordan, 11941